A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
批准号:
3282102
负责人:
PHILLIP H PEKALA
金额:
$9.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1991-08-31
关键词:
DNA methylation RNA adipose tissue affinity labeling bioenergetics cachexia cell differentiation complementary DNA endotoxins enzyme mechanism fatty acid synthase gel electrophoresis genetic transcription gluconeogenesis high performance liquid chromatography insulin laboratory mouse laboratory rabbit laboratory rat lipoprotein lipase macrophage messenger RNA molecular biology monokines nucleic acid hybridization nucleic acid probes pathologic process protein biosynthesis receptor tissue /cell culture tumor necrosis factor alpha
中文摘要
我们正在调查分子事件,
引发感染的生化后遗症 一种临床
患有慢性感染或肿瘤的动物的特征是
存在可发展为恶病质的分解代谢状态,
震惊和死亡 这种现象的生物化学基础是
不被理解,但据推测一旦触发是一个普遍的
自然 为了深入了解这一机制,
过程中,我们选择内毒素血症作为模型系统,
已经将细胞培养技术应用于其研究。
从巨噬细胞系RAW 264.7,
是一种介质的来源,
当加入3 T3-L1脂肪细胞时,
脂蛋白脂酶在合成水平上的活性。 这
纯化至均一的介质被称为恶病质素,
证实与肿瘤坏死因子(TNF)相同。 是
我们的目标是了解TNF
调节细胞代谢。 要做到这一点,关键是首先
表征TNF对脂蛋白脂酶mRNA的影响
水平,该消息的半衰期以及
转录。 我们还将确定TNF是否影响
脂肪酶的分泌。 我们已经观察到TNF刺激
3 T3-L1成纤维细胞的葡萄糖摄取率为250%,而在完全-
分化的脂肪细胞己糖摄取被抑制50%。
葡萄糖进入细胞的这种调节将被表征
通过定量转运蛋白的动力学水平,以及
平衡结合和光亲和标记。 我们还将
检查对mRNA水平和转录速率的影响。
我们已经定义了第二个单核细胞因子的存在,
RAW 264.7细胞的条件培养基,
L 6大鼠糖原消耗和随后的己糖摄取
培养中的肌管。 我们计划纯化这种单核细胞因子,
并量化其对以下方面的影响:己糖摄取、细胞
糖原水平,乳酸盐的产生,并检查
通过结合和光亲和性测定葡萄糖转运蛋白的水平
标签研究。 我们还将确定,如果数量的变化,
是由于运输水平的变化,
mRNA和转录速率。 这些研究将有助于我们
了解这些单核因子是如何产生的
免疫系统暴露于侵入性刺激,能够
调节能量储存组织的新陈代谢。
英文摘要
We are pursuing an investigation of the molecular events that
trigger the biochemical sequelae of infection. One of the clinical
hallmarks of animals with chronic infections or tumors is the
presence of a catabolic state which can proceed to cachexia,
shock, and death. The biochemical basis for this phenomenon is
not understood but presumably once triggered is of a universal
nature. In order to gain insight into the mechanism of this
process, we have selected endotoxemia as a model system and
have applied cell culture techniques to its investigation.
conditioned medium from the macrophage cell line, RAW 264.7,
after exposure to endotoxin was the source of a mediator that
when added to 3T3-L1 adipocytes markedly suppressed the
activity of lipoprotein lipase at the level of synthesis. This
mediator purified to homogeneity was termed cachectin and
demonstrated to be identical to tumor necrosis factor (TNF). It is
our objective to understand the mechanism by which TNF
regulates cellular metabolism. To do this it is critical to first
characterize the effect of TNF on lipoprotein lipase mRNA
levels, the half-life of that message as well as rates of
transcription. We will also determine if TNF affects the rate of
secretion of the lipase. We have observed that TNF stimulates
glucose uptake by 250% in 3T3-L1 fibroblasts while in the fully-
differentiated adipocytes hexose uptake is suppressed by 50%.
This regulation of glucose entry into the cell will be characterized
by quantifying levels of transporter kinetically, as well as by
equilibrium binding and photoaffinity labeling. We will also
examine the effects on mRNA levels and rates of transcription.
we have defined the presence of a second monokine in the
conditioned medium of the RAW 264.7 cells that stimulates
glycogen depletion and subsequently hexose uptake in L6 rat
muscle myotubes in culture. We plan to purify this monokine to
homogeneity and quantify its effects on: hexose uptake, cellular
glycogen levels, lactate production, and examine changes in the
levels of the glucose transporter by binding and photoaffinity
labeling studies. We will also determine if changes in the number
of transporters are due to changes in the levels of transporter
mRNA and rates of transcription. These studies will aid in our
understanding of how these monokines, produced when the
immune system is exposed to invasive stimuli, are capable of
regulating metabolism in energy storage tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel regulatory mechanisms in adipogenesis: role of the ES-cell transcription f
-
批准号:7933449
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2010
-
负责人:PHILLIP H PEKALA
-
依托单位:
REGULATION OF GLUCOSE TRANSPORTER MRNA STABILITY
-
批准号:6517606
-
项目类别:
-
资助金额:$18.71万
-
财政年份:1999
-
负责人:PHILLIP H PEKALA
-
依托单位:
REGULATION OF GLUCOSE TRANSPORTER MRNA STABILITY
-
批准号:6178023
-
项目类别:
-
资助金额:$17.64万
-
财政年份:1999
-
负责人:PHILLIP H PEKALA
-
依托单位:
REGULATION OF GLUCOSE TRANSPORTER MRNA STABILITY
-
批准号:2834907
-
项目类别:
-
资助金额:$18.03万
-
财政年份:1999
-
负责人:PHILLIP H PEKALA
-
依托单位:
REGULATION OF GLUCOSE TRANSPORTER MRNA STABILITY
-
批准号:6381537
-
项目类别:
-
资助金额:$18.17万
-
财政年份:1999
-
负责人:PHILLIP H PEKALA
-
依托单位:
MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282097
-
项目类别:
-
资助金额:$13.04万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282098
-
项目类别:
-
资助金额:$1.96万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282101
-
项目类别:
-
资助金额:$6.23万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282103
-
项目类别:
-
资助金额:$10.65万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282099
-
项目类别:
-
资助金额:$0.35万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282104
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282095
-
项目类别:
-
资助金额:$11.25万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
A MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:3282100
-
项目类别:
-
资助金额:$6.86万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:2176779
-
项目类别:
-
资助金额:$12.69万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
MACROPHAGE ENDOGENOUS FACTOR THAT SUPPRESSES ANABOLISM
-
批准号:2176780
-
项目类别:
-
资助金额:$13.06万
-
财政年份:1984
-
负责人:PHILLIP H PEKALA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
基于异质人群多源数据识别单细胞 RNA数量性状风险位点的统计学方法研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蔡铭轩
-
依托单位:
uN2CpolyG蛋白经ALYREF蛋白介导RNA转运异常在神经元核内包涵体病发病中的作用及机制研究
-
批准号:2026JJ60587
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张思哲
-
依托单位:
病毒非编码RNA多样性图谱构建及其生物发生与致病机制研究
-
批准号:2026JJ60389
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:傅萍
-
依托单位:
核糖核酸酶RNase E与其抑制因子RebA通过液-液相分离调控蓝藻RNA代谢的分子机制
-
批准号:JCZRQNB202600879
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: